Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kumar Prabhash

Showing results (181-190 of 469) with videos related to

Pageof 47
Sort By:
Ecancermedicalscience|March 28, 2019
ROS1 mutation non-small cell lung cancer-access to optimal treatment and outcomesAmit Joshi, Nikhil Pande, Vanita Noronha, et al.
Chemotherapy Research and Practice|December 31, 2014
The Importance of Brain Metastasis in EGFR Mutation Positive NSCLC PatientsVanita Noronha, Amit Joshi, Anant Gokarn, et al.
Ecancermedicalscience|February 25, 2022
Efficacy and safety of neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin and oral metronomic chemotherapy (OMCT) in patients with technically unresectable oral squamous cell carcinoma (OSCC)Lakhan Kashyap, Vijay Patil, Vanita Noronha, et al.
Oncotargets and Therapy|June 28, 2017
Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatmentVanita Noronha, Anuradha Choughule, Vijay M Patil, et al.
JAMA Otolaryngology-- Head & Neck Surgery|September 4, 2020
Outcomes of a Telephone-Based Questionnaire for Follow-up of Patients Who Have Completed Curative-Intent Treatment for Oral CancersAkshat Malik, Sudhir Nair, Kavita Sonawane, et al.
The Oncologist|May 24, 2017
Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate DataPetr Szturz, Kristien Wouters, Naomi Kiyota, et al.
Oncotargets and Therapy|April 14, 2017
<i>EGFR</i> mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?Amit Joshi, Saurabh Zanwar, Vanita Noronha, et al.
Indian Journal of Cancer|August 8, 2018
Efficacy of crizotinib in ALK mutant non-small cell lung cancers that are positive by IHC but negative by FISH compared to FISH positive casesSaurabh Zanwar, Vanita Noronha, Amit Joshi, et al.
Oral Oncology|September 20, 2022
Long term outcomes of a randomized controlled clinical trial comparing the efficacy of Cabazitaxel versus docetaxel as second-line or above therapy in recurrent head and neck cancerVijay Patil, Sravan Kumar, Vanita Noronha, et al.
Journal of Cancer Research and Therapeutics|July 29, 2020
Head and neck squamous cell carcinoma in HIV, HBV and HCV seropositive patients - Prognosis and its predictorsSupreet Singh Nayyar, Shivakumar Thiagarajan, Akshat Malik, et al.
Pageof 47

Showing results (181-190 of 469) with videos related to

Sort By:
Pageof 47
Ecancermedicalscience|March 28, 2019
ROS1 mutation non-small cell lung cancer-access to optimal treatment and outcomesAmit Joshi, Nikhil Pande, Vanita Noronha, et al.
Chemotherapy Research and Practice|December 31, 2014
The Importance of Brain Metastasis in EGFR Mutation Positive NSCLC PatientsVanita Noronha, Amit Joshi, Anant Gokarn, et al.
Ecancermedicalscience|February 25, 2022
Efficacy and safety of neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin and oral metronomic chemotherapy (OMCT) in patients with technically unresectable oral squamous cell carcinoma (OSCC)Lakhan Kashyap, Vijay Patil, Vanita Noronha, et al.
Oncotargets and Therapy|June 28, 2017
Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatmentVanita Noronha, Anuradha Choughule, Vijay M Patil, et al.
JAMA Otolaryngology-- Head & Neck Surgery|September 4, 2020
Outcomes of a Telephone-Based Questionnaire for Follow-up of Patients Who Have Completed Curative-Intent Treatment for Oral CancersAkshat Malik, Sudhir Nair, Kavita Sonawane, et al.
The Oncologist|May 24, 2017
Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate DataPetr Szturz, Kristien Wouters, Naomi Kiyota, et al.
Oncotargets and Therapy|April 14, 2017
<i>EGFR</i> mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?Amit Joshi, Saurabh Zanwar, Vanita Noronha, et al.
Indian Journal of Cancer|August 8, 2018
Efficacy of crizotinib in ALK mutant non-small cell lung cancers that are positive by IHC but negative by FISH compared to FISH positive casesSaurabh Zanwar, Vanita Noronha, Amit Joshi, et al.
Oral Oncology|September 20, 2022
Long term outcomes of a randomized controlled clinical trial comparing the efficacy of Cabazitaxel versus docetaxel as second-line or above therapy in recurrent head and neck cancerVijay Patil, Sravan Kumar, Vanita Noronha, et al.
Journal of Cancer Research and Therapeutics|July 29, 2020
Head and neck squamous cell carcinoma in HIV, HBV and HCV seropositive patients - Prognosis and its predictorsSupreet Singh Nayyar, Shivakumar Thiagarajan, Akshat Malik, et al.
Pageof 47